The Trader Harbor
  • Business
  • Politics
  • World News
  • Stocks
  • Business
  • Politics
  • World News
  • Stocks

The Trader Harbor

Politics

Trump doubles down on voiding Biden autopen actions, including pardons and commutations

by admin December 3, 2025
December 3, 2025
Trump doubles down on voiding Biden autopen actions, including pardons and commutations

President Donald Trump announced in a Truth Social post on Tuesday that he would ‘fully and completely’ terminate any documents signed by former President Joe Biden’s autopen, including pardons and commutations.

‘Any and all Documents, Proclamations, Executive Orders, Memorandums, or Contracts, signed by Order of the now infamous and unauthorized ‘AUTOPEN,’ within the Administration of Joseph R. Biden Jr., are hereby null, void, and of no further force or effect,’ Trump wrote.

‘Anyone receiving ‘Pardons,’ ‘Commutations,’ or any other Legal Document so signed, please be advised that said Document has been fully and completely terminated, and is of no Legal effect. Thank you for your attention to this matter!’

This post appeared first on FOX NEWS

0
FacebookTwitterGoogle +Pinterest
previous post
Hegseth erupts over WaPo ‘fake stories’, vows to stop ‘poisoning of the American people’
next post
Hegseth erupts over WaPo ‘fake stories’ smear, vows to stop ‘poisoning of the American people’

Related Posts

Trump admin weighs terrorism sanctions against UN Palestinian...

December 11, 2025

Trump’s Kennedy Center Honors overhaul delivers star-studded lineup,...

December 7, 2025

Zelenskyy seeks ‘strong reaction’ from US if Putin...

August 22, 2025

Johnson urges Biden to intervene in ICC’s reported...

April 30, 2024

Government limps deeper into shutdown crisis with no...

October 8, 2025

Senate GOP divided as millions risk losing food...

October 29, 2025

New poll reveals what Americans think of Trump’s...

December 12, 2024

Harris campaign claims she no longer supports fracking...

July 27, 2024

Who is Karoline Leavitt?: A look at the...

November 30, 2024

Medical groups urge Kennedy, FDA to reexamine broad...

July 8, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • The Real Drivers of This Market: AI, Semis & Robotics

      February 1, 2026
    • S&P 500 Breaking Out Again: What This Means for Your Portfolio

      February 1, 2026
    • IDF says Gaza strikes hit terrorists, weapons facilities after ceasefire breach; hospitals report 30 killed

      February 1, 2026
    • Spencer Pratt says A-listers privately cheer his criticism of California leadership, fear career fallout

      February 1, 2026
    • Noem touts TSA success after thousands with terror links barred from flights at major US airport

      February 1, 2026
    • Hundreds rally outside Iranian UN ambassador’s Fifth Avenue residence calling for regime change

      February 1, 2026

    Categories

    • Business (1,449)
    • Politics (5,678)
    • Stocks (1,927)
    • Uncategorized (45)
    • World News (1,442)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheTraderHarbor, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 thetraderharbor.com | All Rights Reserved